Bufrolin

Overview

Bufrolin is a Cromoglycate (histamine release inhibitor) analog and a high potency agonist of GPR35 . Bufrolin promotes interactions between β-arrestin-2 and either human GPR35a or rat GPR35 . Bufrolin also serves as antiallergic mast cell stabilizer and inhibit an anti-inflammatory response inducible by the internalization peptide. Bufrolin acts as an anti-inflammatory agent to be used in research of delivering pharmacol linked with internalization peptide.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > GPR35 | Products > Signaling Pathways > Histamine Receptor

Product Information

• Catalog No.: HY-106481
• CAS No.: 54867-56-0
• Molecular Formula: C18H16N2O6
• Molecular Weight: 356.33
• Purity: 95.16%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source